Abstract
Second-generation antihistamines are unquestionably the first-line treatment for chronic urticaria and can be used at higher than licensed doses if normal doses fail to control the disease. A short course of oral corticosteroids should be considered for patients not responding to antihistamines before trying other immunosuppressive drugs. Ciclosporin is effective in most antihistamine-resistant patients who require long-term corticosteroid treatments to control their disease. Omalizumab is effective in most subsets of chronic urticaria sufferers who do not respond to other treatments but its high cost represents a limitation to its widespread use.
Original language | English |
---|---|
Pages (from-to) | 105-116 |
Number of pages | 12 |
Journal | Immunology and Allergy Clinics of North America |
Volume | 34 |
Issue number | 1 |
DOIs | |
Publication status | Published - Feb 2014 |
Keywords
- Antihistamines
- Chronic urticaria
- Ciclosporin
- Corticosteroids
- Omalizumab
- Therapy
ASJC Scopus subject areas
- Immunology and Allergy
- Immunology